Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Home
/
Trials
/
NCT00420836
NCT00420836
View on ClinicalTrials.gov
Tobramycin Administered by eFlow Rapid Nebulizer: Pharmacokinetic Study
PHASE1
Completed
INTERVENTIONAL
Enrollment
20
Participants
Timeline
Start Date
April 30, 2006
Conditions
Cystic Fibrosis
Interventions
DRUG
Tobramycin
Sponsors
Lead Sponsor
Novartis
All Listed Sponsors
lead
Novartis
INDUSTRY